secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0001193125-25-039256
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics CMO Lisa von Moltke resigns effective March 14, 2025
-----------------------------------------------------------------------

- Lisa von Moltke, M.D., notified Seres of her resignation as EVP and Chief Medical Officer.
- Resignation effective March 14, 2025; she accepted a CMO and Head of R&D role at a biopharma.
- No successor named; search process not disclosed.
- Dr. von Moltke's departure is for a role in autoimmune disease therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312525039256/0001193125-25-039256-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312525039256/d928060d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-039256

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer